FOIA Request Shows GSK Touted Off-Label Avodart Use
GlaxoSmithKline PLC reportedly admitted in 2009 that it had not disclosed its role in funding a medical journal supplement that suggested off-label uses for its prostate reduction pill Avodart....To view the full article, register now.
Already a subscriber? Click here to view full article